Revisiting ACCORD: Should Blood Pressure Targets in People With and Without Type 2 Diabetes Be Different? - 05/12/22
Doi : 10.1016/j.amjmed.2022.07.023
Cindy Xinxin Du, MD a, Chenxi Huang, PhD b, Yuan Lu, ScD b, c, Erica S. Spatz, MD, MHS b, c, Kasia J. Lipska, MD d, e, Harlan M. Krumholz, MD, SM b, c, d, ⁎ 
a University of Pittsburgh Medical Center, Pa
b Center for Outcomes Research and Evaluation, Yale New Haven Hospital, Conn
c Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn
d Department of Health Policy and Management, Yale School of Public Health, New Haven, Conn
e Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn
⁎Requests for reprints should be addressed to Harlan M. Krumholz, MD, SM, 195 Church Street, Fifth Floor, New Haven, CT 06510.195 Church Street, Fifth Floor, New HavenCT06510
Le texte complet de cet article est disponible en PDF.
| Funding: This work did not receive direct funding. |
|
| Conflicts of Interest: In the past 3 years, KJL received support from the National Institutes of Health and the Patient-Centered Outcomes Research Institute, royalties from UpToDate to write and edit content, and other support from the Centers for Medicare & Medicaid Services to develop and evaluate publicly reported quality measures. In the past 3 years, HMK received expenses or personal fees from UnitedHealth, Element Science, Aetna, Reality Labs, Tesseract/4Catalyst, F-Prime, The New England Journal of Medicine, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, and Martin/Baughman Law Firm. He is a co-founder of Refactor Health and HugoHealth, and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare & Medicaid Services and through Yale University from Johnson & Johnson. CXD was affiliated with the Yale School of Medicine during the time the work was conducted. CXD, CH, YL, and ES report no potential conflicts of interest. |
|
| Authorship: All authors of this Commentary had access to the data and played a part in the writing. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 136 - N° 1
P. 6-8 - janvier 2023 Retour au numéro
Article précédent
- Newest Guidance and Evidence for Health Care Providers: COVID-19 and Other Vaccines
- Alexandra Rubenstein, Sarah K. Wood, Vama Jhumkhawala, Mark J. DiCorcia, Dennis G. Maki, Charles H. Hennekens
- The Colorado Option: The Next Staging Ground for Health Equity?
- Wasan M. Kumar, Eli Y. Adashi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?